Location: Home
  • search
  • go
  • Relate News
  • 3/28/2023CDE Issues the Technical Guidelines for the Application of Physiologic...
  • 3/28/2023NHSA Issues the NHSA Notice on Improving the Price Formation Mechanism...
  • 3/28/2023Chinese Scientists Develop New Vaccine Strategy by Entrapping Live Vir...
  • 3/27/2023BioNTech and Oncoc4 Sign Strategic Collaboration for Novel Checkpoint ...
  • 3/27/2023NCC: China's Tumor Registration System Covers 1.407B Population
  • 3/27/2023AstraZeneca to Further Expand R&D Presence in China
  • 3/27/2023Hepalink's OncoVent Enter License Deal with Orient EuroPharma for Oreg...
  • 3/24/2023InvoX Pharma's F-star Announces 2nd Licence Deal with Takeda
  • 3/24/2023Brii Bio Drops Once-promising COVID Cocktail for Variants
  • 3/24/2023AstraZeneca's Blood Cancer Drug Calquence Gets Conditional Approval in...
  • 3/24/2023NMPA Publishes the 2022 Annual Report for Adverse Drug Reaction Monito...
  • 3/24/2023NMPA Issues the Procedures for Adjustment of Published Reference Formu...
  • 3/24/2023CDE Issues the "Common Pharmacy Issues and Related Technical Requireme...
  • 3/24/2023CDE Issues the Technical Guidelines for Clinical Research and Developm...
  • 3/24/2023Pfizer Signs MOU with HCRC Aimed at Improving Rural Health in China
  • 3/24/2023New Report: Incidence of Moderate and Severe Ovarian Hyperstimulation ...
  • 3/24/2023Drug R&D and Product Registration News Digest March 2023 (4)
  • 3/24/2023U.S.-China Collaboration Could Cut Development Time, Cost For New Canc...
  • 3/23/2023Roche, CR Pharma Tie Up to Improve Access of Flu Drug Xofluza in Chna
  • 3/23/2023Chinese Government Issues the Opinions for Further Improving Healthcar...
  • 3/23/2023CDE Solicits Comments on the Dossier Requirements for Marketing Regist...
  • 3/22/2023Biohaven Licenses ex-China Rights of Highlightll Pharma's TYK2/JAK1 Du...
  • 3/22/2023NMPA Issues Announcement for Applicability of ICH Guidelines S1B(R1)/Q...
  • 3/22/2023CDE Solicits Comments on the Technical Guidelines for Virus Removal/In...
  • 3/22/2023TaiGen Enters Exclusive License Agreement with Joincare for Pan-influe...
  • 3/21/2023Chinese NCE Drug Approval in 2022: Import vs. Domestic
  • 3/21/2023Review of Chinese Drug Registration Application and Evaluation in 2022
  • 3/21/2023Bayer, Orion's Nubeqa Gets Approval in China for Expanded Use in Prost...
  • 3/21/2023CDE Issues the Technical Guidelines for Clinical Research and Developm...
  • 3/21/2023CDE Issues the Technical Guidelines for Writing of Pharmacy Informatio...
  • Page:160/827 Total number of articles:24792: [First][<<] [158] [159] [160] [161] [162] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group